Medicrime Convention Against Counterfeit Drugs To Enter Into Force In 201601/10/2015 by Catherine Saez, Intellectual Property Watch 1 CommentShare this Story:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Google+ (Opens in new window)Click to share on Facebook (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window)Much of our best content is available only to IP Watch subscribers. We are a non-profit independent news service, and subscribing to our service helps support our goals of bringing more transparency to global IP and innovation policies. To access all of our content, please subscribe now.The ratification of an international convention to fight counterfeit of medical products by Guinea has unlocked the entry into force of the instrument, now set to happen on 1 January 2016. The Council of Europe Convention on the Counterfeiting of Medical Products and Similar Crimes involving threats to Public Health (Medicrime Convention) was adopted in December 2010. It has been signed by 24 countries and ratified by five of them: Hungary, Moldova, Spain, Ukraine, and lately Guinea on 24 September.The convention is a binding international instrument. According to the Council of Europe, “Incidences of counterfeit medical products and similar crimes undermine public trust in healthcare systems and authorities’ surveillance …”The Council of Europe (COE) is a pan-European political organisation including 47 member states in Europe.The COE has published a webpage on the Medicrime Convention, here. But a fuller understanding of how this agreement will impact counterfeiting remains to be seen.Global pharmaceutical associations welcomed the entry into force of the Medicrime Convention.According to a press release [pdf], Eduardo Pisani, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) said, “The fight against counterfeit medicines is gaining momentum. Strong legislative frameworks are necessary to combat counterfeit medicines and Medicrime is a unique tool that can curb this problem.”“Counterfeit medicines can have the wrong active ingredients, the wrong dose or dangerous substances and could result in drug resistance, further illness or disability or even death,” according to the release.This definition has been regularly contested by civil society since a “counterfeit” product generally relates to an intellectual property infringement rather than a sub-standard product. Image Credits: drugs.comShare this Story:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Google+ (Opens in new window)Click to share on Facebook (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window)RelatedCatherine Saez may be reached at firstname.lastname@example.org."Medicrime Convention Against Counterfeit Drugs To Enter Into Force In 2016" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.